• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
US currency next to a ruler pen and calculator
Special Reports

Top 10 pharma R&D budgets of 2025

All of the companies on this year's list also made last year's ranking, but most of them made substantial cuts to their R&D spending.
Darren Incorvaia Mar 30, 2026 3:00am
medicine artificial intelligence

Lilly embraces AI biotech Insilico again, inking $2.75B collab

Mar 29, 2026 8:00pm
Fierce Biotech43png

Scaling Radioligand Therapy: Expanding the Impact of Theranostics

Brought to you by Curium
Amethyst diamond crystal

Biogen’s litifilimab sparkles in midphase lupus trial

Mar 30, 2026 4:45am
Measuring tape on top of cash

Kailera plots IPO to fund Hengrui-licensed obesity pipeline

Mar 30, 2026 3:45am
Honeybee sticking head into honeypot

Astellas axes early trial for Sjögren’s syndrome

Mar 30, 2026 2:18pm
More News

Blackstone closes record $6.3B life sciences fund

Mar 30, 2026 1:50pm

Merck dives into data showing PCSK9 pill easily outswims rivals

Mar 30, 2026 11:45am

Boston Scientific heart plug stands up to blood thinners at ACC

Mar 30, 2026 11:02am

Kevin Tang uses control of Aurinia to finally take over Kezar

Mar 30, 2026 10:53am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings